Nuveen’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.3M Buy
3,243,643
+21,922
+0.7% +$294K 0.01% 750
2025
Q4
$40.6M Sell
3,221,721
-3,511
-0.1% -$40.2K 0.01% 750
2025
Q3
$32.3M Buy
3,225,232
+569,216
+21% +$5.11M 0.01% 842
2025
Q2
$21.5M Buy
2,656,016
+319,388
+14% +$2.41M 0.01% 1058
2025
Q1
$19.6M Sell
2,336,628
-399,115
-15% -$3.33M 0.01% 1142
2024
Q4
$21.7M Sell
2,735,743
-184,836
-6% -$1.55M 0.01% 1143
2024
Q3
$24.3M Buy
2,920,579
+389,210
+15% +$3.04M 0.01% 1057
2024
Q2
$16.1M Buy
2,531,369
+573,162
+29% +$3.64M ﹤0.01% 1276
2024
Q1
$11.9M Hold
1,958,207
﹤0.01% 1498
2023
Q4
$11.9M Buy
1,958,207
+108,606
+6% +$484K ﹤0.01% 1482
2023
Q3
$7.81M Buy
1,849,601
+851,383
+85% +$3.18M ﹤0.01% 1620
2023
Q2
$3.09M Buy
998,218
+700,648
+235% +$1.49M ﹤0.01% 2145
2023
Q1
$413K Sell
297,570
-214,226
-42% -$427K ﹤0.01% 2849
2022
Q4
$1.02M Sell
511,796
-285,453
-36% -$640K ﹤0.01% 2673
2022
Q3
$1.61M Sell
797,249
-582,227
-42% -$1.63M ﹤0.01% 2513
2022
Q2
$4.39M Sell
1,379,476
-698,805
-34% -$2.53M ﹤0.01% 2031
2022
Q1
$8.42M Buy
2,078,281
+271,010
+15% +$1.2M ﹤0.01% 1760
2021
Q4
$7.14M Buy
1,807,271
+111,703
+7% +$557K ﹤0.01% 1891
2021
Q3
$8.56M Sell
1,695,568
-528,577
-24% -$2.66M ﹤0.01% 1891
2021
Q2
$11.4M Sell
2,224,145
-85,762
-4% -$487K ﹤0.01% 1788
2021
Q1
$15.5M Buy
2,309,907
+1,734,350
+301% +$9.61M ﹤0.01% 1505
2020
Q4
$2.63M Buy
575,557
+174,464
+43% +$773K ﹤0.01% 2369
2020
Q3
$1.56M Sell
401,093
-109,883
-22% -$470K ﹤0.01% 2482
2020
Q2
$2.43M Sell
510,976
-32,593
-6% -$134K ﹤0.01% 2252
2020
Q1
$1.89M Sell
543,569
-210,855
-28% -$893K ﹤0.01% 2222
2019
Q4
$3.64M Buy
754,424
+366,995
+95% +$1.28M ﹤0.01% 2149
2019
Q3
$1.12M Buy
387,429
+38,081
+11% +$133K ﹤0.01% 2650
2019
Q2
$2.5M Buy
+349,348
New +$3.57M ﹤0.01% 2326

Other funds holding AMRX